coronavirus research

The Latest

  • Omicron Defeats Johnson & Johnson Vaccine Antibodies
    Vaccine
    In a laboratory experiment, J&J's vaccine produced some antibodies but demonstrated "no detectable" neutralization of the Omicron coronavirus variant.
  • Frontline Stories: COVID-19 Scientists Can’t See The Finish Line
    NEW VARIANT
    Pandemic scientists on the frontline feel burned out, hopeless, and even “empty.”
  • Who's Ready To Be A Paid-Volunteer And Get Infected With COVID-19?
    LOCKDOWN
    Britain approved a study that will intentionally infect volunteers with the novel coronavirus.
  • Synairgen Drug Shows Promising Results In COVID-19 Trial
     A woman holds a small bottle labeled with a
    Patients were two to three times more likely to recover to the point where everyday activities were not compromised by their illness, Synairgen claims.
  • Scientists Agree More Bat Research Is Needed To Prevent Next Pandemic
    FILE PHOTO: A computer image created by Nexu Science Communication together with Trinity College in Dublin
    As the current pandemic shows, knowledge gap is dangerous -- and scientists agree.
  • Researchers Analyze Global Sentiments Surrounding The COVID-19 Pandemic
    FILE PHOTO: People wearing protective face masks amid the outbreak of the coronavirus disease (COVID-19) walk out of a metro station in Kyiv, Ukraine July 15, 2020.
    The study aims to examine worldwide trends of four emotions—fear, anger, sadness, and joy—and the narratives underlying those emotions during the COVID-19 pandemic.
  • China's COVID-19 Vaccine Produces Immune Response In Phase 2 Trial
    COVID-19 VACCINE
    The Phase 2 trial involved more than 500 people in Wuhan.
  • Data Secrecy Worsening COVID-19 Spread, Scientists Say
    Covid-19
    Scientists are complaining they can’t get all the data they need on results from coronavirus testing sites or on hospitalized patients, which they believe will cripple attempts to slow COVID-19’s spread in the U.S.
  • Moderna Seeking More Volunteers As Phase 1 COVID Vaccine Trial Shows Promising Results
    COVID-19 Vaccine
    Moderna was the first company in the U.S. to begin testing coronavirus vaccines on humans, giving its first dose on March 16.
  • COVID-19 May Cause Neurological Problems, Study Finds
    ICU patient
    Published in the journal Brain, the research team identified one rare and sometimes fatal inflammatory condition, known as ADEM, which appears to be increasing in prevalence due to the pandemic.
1   2   3